Aquestive Therapeutics (AQST) Research & Development (2017 - 2026)
Aquestive Therapeutics (AQST) reported Research & Development of $3.96 million for Q2 2026, down 3.5% from $4.11 million a year earlier and down 5.8% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Research & Development (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aquestive Therapeutics' Research & Development came in at $15.89 million, down 19.1% year-over-year; for FY2025, it came in at $17.19 million, down 15.2% from FY2024.
- Research & Development has a five-year compound annual growth rate of -2.9% (FY2020 to FY2025).
- By year, Research & Development came in at $20.28 million in FY2024 (+54.8%), $13.1 million in FY2023 (-25.0%), $17.48 million in FY2022 (+2.5%) and $17.05 million in FY2021 (-14.3%).
- Five-year quarterly Research & Development spans a low of $2.89 million in Q4 2023 and a high of $5.93 million in Q1 2024.
- Year over year, Research & Development has now declined in each of the last six quarters, with growth averaging 6.3% over the last eight quarters.
- The high point for year-over-year Research & Development in five years was Q4 2024 (growth of 70.3%); the low point was Q4 2025 (a decline of 35.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.2 million (Q1 2026), $3.2 million (Q4 2025) and $4.53 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Aquestive Therapeutics | 596.18 Mn | 136.72 Mn | 9.80 Mn | 3.96 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.96 Mn |
| Mar 31, 2026 | 4.20 Mn |
| Dec 31, 2025 | 3.20 Mn |
| Sep 30, 2025 | 4.53 Mn |
| Jun 30, 2025 | 4.11 Mn |
| Mar 31, 2025 | 5.36 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Mar 31, 2024 | 5.93 Mn |
| Dec 31, 2023 | 2.89 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 3.47 Mn |
| Mar 31, 2023 | 3.55 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 3.23 Mn |
| Jun 30, 2022 | 5.20 Mn |
| Mar 31, 2022 | 4.77 Mn |
| Dec 31, 2021 | 4.40 Mn |
| Sep 30, 2021 | 4.73 Mn |
API Access
Aquestive Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();